CS, Y., TP, L., VY, L., TB, T., & VS, Y. (2023). Biomarkers for immune checkpoint inhibition in sarcomas - are we close to clinical implementation? Biomarker research, 11(1), 75. https://doi.org/10.1186/s40364-023-00513-5
Chicago Style (17th ed.) CitationCS, Yiong, Lin TP, Lim VY, Toh TB, and Yang VS. "Biomarkers for Immune Checkpoint Inhibition in Sarcomas - Are We Close to Clinical Implementation?" Biomarker Research 11, no. 1 (2023): 75. https://doi.org/10.1186/s40364-023-00513-5.
MLA (9th ed.) CitationCS, Yiong, et al. "Biomarkers for Immune Checkpoint Inhibition in Sarcomas - Are We Close to Clinical Implementation?" Biomarker Research, vol. 11, no. 1, 2023, p. 75, https://doi.org/10.1186/s40364-023-00513-5.
Warning: These citations may not always be 100% accurate.